TrialProstate cancer and prostatic diseases2024

Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer.

Robert Hugh Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.